DocG DocG | AI-Powered Clinical Summaries
← DocG Medical Summaries

Top Psychiatry Research Papers

Live ranking — trailing 6 months, each paper's latest score Scores fold Psychiatry Relevance & Applicability into the quality dimensions; papers scored before the dynamic-specialty rubric keep their original score Showing the top 10 of 395 ranked articles — sign in free for the full ranking and per-criterion score breakdowns
1. 7.3
Adjunctive Antipsychotics in Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.
Overall: A large, methodologically strong network meta-analysis offers useful short-term comparative guidance for a common condition, but absent absolute effects and limited maintenance evidence constrain its clinical impact.
2. 7.2
Physical activity and perinatal depression and anxiety: a global umbrella review and meta-meta-analysis.
Overall: A rigorous umbrella review reports meaningful symptom improvement from accessible physical activity, but heterogeneity, limited anxiety evidence, absent safety and adherence data, and reliance on symptom scales temper its immediate practice-changing impact.
3. 7.2
Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial.
Overall: This multisite US randomized trial found sustained but modest patient-important benefits from a more accessible CBT model, with meaningful scalability balanced by incomplete follow-up and ongoing coaching and technology requirements.
4. 7.0
Ventricular Arrhythmia and Sudden Death Risk With Concomitant Antipsychotic and SSRI Use.
Overall: This large, methodologically careful observational study identifies a clinically serious prescribing risk relevant to US outpatient care, but rare events, residual confounding, and missing absolute risks temper its impact.
5. 7.0
Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.
Overall: This large US comparative-effectiveness study found a modest reduction in nonfatal overdose with buprenorphine-naloxone but no mortality advantage, providing clinically useful yet nonrandomized evidence for outpatient treatment selection after opioid withdrawal.
6. 7.0
Optimising and personalising task-shared psychosocial interventions for common mental disorders: a Bayesian component network meta-analysis of individual participant data.
Overall: A large, prespecified participant-level synthesis identifies potentially beneficial and detrimental therapy components, but uncertain clinical thresholds, durability, harms, and US implementation limit its immediate practice-changing force.
7. 6.9
Psychotherapy for Impact of Killing During War: A Randomized Clinical Trial.
Overall: A well-designed US randomized trial found a moderate functional benefit from a targeted psychotherapy, but mixed primary outcomes, modest sample size, and limited burden and implementation data temper its impact.
8. 6.9
Clinical effectiveness of internet-delivered self-help Aacceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS): a multicentre, parallel, randomised controlled trial.
Overall: A well-conducted randomized trial found a moderate, clinically meaningful short-term reduction in caregiver anxiety with minimal reported harm and promising scalability, though attrition, limited follow-up, and the UK setting temper immediate US practice impact.
9. 6.9
Efficacy of a Conversational AI Agent for Psychiatric Symptoms and Digital Therapeutic Alliance: A Randomized Clinical Trial.
Overall: A comparatively large randomized trial found patient-relevant but mostly modest benefits from conversational AI, although narrow generalizability and missing safety and implementation details limit immediate practice change.
10. 6.9
Safety and effectiveness of strategies to deprescribe chronic benzodiazepine receptor agonist use in older adults: a systematic review.
Overall: This broadly relevant systematic review supports structured, gradual benzodiazepine receptor agonist deprescribing as feasible and generally safe, but heterogeneous evidence and absent quantitative effects limit certainty about patient-level benefit.
Score Guide: 9-10 Exceptional 7-8 Strong 5-6 Moderate 3-4 Weak 1-2 Poor

Get the top Psychiatry papers in your inbox

Free 300-word clinical summaries 3× per week, plus the full ranking of all 395 recent Psychiatry papers with per-criterion AI score breakdowns.

Sign Up Free